Argonaute RNA: Funding, Investors & Team (Sep 2026)
Argonaute RNA company research projects build on existing intellectual property.
Argonaute RNA has raised $1.8M across 1 funding round on record, the most recent an undisclosed round of $1.8M announced in Sep 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Argonaute RNA Company Profile and Key Stats
Latest funding round on record: Sep 2026.
Argonaute RNA Funding Rounds
Argonaute RNA Investors
Argonaute RNA Founders and Leadership Team
Contact details for the Argonaute RNA team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Argonaute RNA Funding Compared to Other Biotechnology Startups
Argonaute RNA's latest round of $1.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Argonaute RNA in Biotechnology and Bristol
Companies Similar to Argonaute RNA
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…
Argonaute RNA Funding FAQs
What does Argonaute RNA do?
Argonaute RNA company research projects build on existing intellectual property.
How much funding has Argonaute RNA raised?
Argonaute RNA has raised $1.8M across 1 round on record. The most recent is an undisclosed round of $1.8M announced in Sep 2026.
When did Argonaute RNA last raise funding?
Argonaute RNA's most recent funding round on record is an undisclosed round of $1.8M, announced in Sep 2026.
Who has invested in Argonaute RNA?
Investors on record for Argonaute RNA include Development Bank of Wales, Empirical Ventures, The Fink Family Office, Bristol Private Equity Club.
Who is the CEO of Argonaute RNA?
Michael Khan is listed as Chief Executive Officer at Argonaute RNA.
Where is Argonaute RNA headquartered?
Argonaute RNA is based in Bristol, United Kingdom.
How many employees does Argonaute RNA have?
Argonaute RNA is in the 11-50 employee band.
When was Argonaute RNA founded?
Argonaute RNA was founded in 2015.
How does Argonaute RNA's funding compare to other Biotechnology startups?
Argonaute RNA's latest round of $1.8M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Argonaute RNA Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Argonaute RNA is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.